The hellp syndrome: A review

Current Women's Health Reviews

Volumn 7, Issue 2, 2011, Pages 125-135

  Moodley, Jack ^a   Khedun, Shaum ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Hypertension; Management; Neonatal outcome; Pre eclampsia; Proteinuria

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIHYPERTENSIVE AGENT; ANTITHROMBIN; ASPARTATE AMINOTRANSFERASE; CORTICOSTEROID; DEXAMETHASONE; FUROSEMIDE; HEPARIN; LACTATE DEHYDROGENASE; ORAL CONTRACEPTIVE AGENT;

ACUTE DISEASE; ACUTE KIDNEY FAILURE; ARTICLE; ASCITES; BRAIN HEMORRHAGE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBRAL PALSY; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DELIVERY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DIURESIS; DRUG MEGADOSE; ECLAMPSIA; EPISIOTOMY; EYE DISEASE; FATTY LIVER; GESTATIONAL AGE; HELLP SYNDROME; HEMATOLOGIC DISEASE; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFECTION COMPLICATION; KIDNEY DISEASE; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER DISEASE; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LOW DRUG DOSE; MATERNAL HYPERTENSION; MATERNAL MORTALITY; MEDICAL SPECIALIST; MISSISSIPPI TRIPLE CLASS SYSTEM; NEWBORN DEATH; NONHUMAN; PANCREATITIS; PATHOGENESIS; PERINATAL MORBIDITY; PERINATAL MORTALITY; PLASMAPHERESIS; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; PROTEINURIA; PUERPERIUM; REGIONAL ANESTHESIA; RESPIRATORY DISTRESS SYNDROME; RETROPERITONEAL HEMATOMA; SEPSIS; SOLUTIO PLACENTAE; SYSTEMIC LUPUS ERYTHEMATOSUS; TENNESSEE CLASSIFICATION SYSTEM; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 79955717997     PISSN: 15734048     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340411795445839     Document Type: Article

References (91)

1. Weinstein L. Syndrome of haemolysis, elevated liver enzymes, andlow platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142: 159-67.
2. Ertan AK, Wagner S, Hendrik HJ, Tanriverdi HA, Schmidt W.Clinical and biophysical aspects of HELLP-syndrome. J PerinatMed 2002; 30: 483-89.
3. Celik C, Gezginc K, Altintepe L, et al. Results of the pregnancieswith HELLP syndrome. Renal Failure 2003; 25: 613-8.
4. Sibai BM. Diagnosis, controversies, and management of the syndromeof hemolysis, elevated liver enzymes, and low plateletcount. Obstet Gynecol 2004; 103: 981-91.
5. Martin JN, Jr, Rose CH, Briery CM. Understanding and managingHELLP syndrome: the integral role of aggressive glucocorticoidsfor mother and child. Am J Obstet Gynecol 2006; 195: 914-34.
6. Beucher G, Simonet T, Dreyfus M. Management of HELLP syndrome. Gynecol Obstet Fertility 2008; 36(12): 1175-90.
7. Lee NM, Brady CW. Liver disease in pregnancy. World J Gastroenterol 2009; 15(8): 897-905.
8. Rath W, Faridi A, Dudenhausen JW. HELLP syndrome. J PerinatMed 2000; 28: 249-60.
9. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome:clinical issues and management, A Review. BMC PregnancyChildbirth 2009; 9: 8-26.
10. Barton JR, Sibai BM. Diagnosis and management of hemolysis,elevated liver enzymes, and low platelets syndrome. Clin Perinatol 2004; 31: 807-33.
11. Matsuda M, Mitsuhashi S, Watarai M, Yamamoto K, Hashimoto T, Ikeda S. Hemolysis, elevated liver enzymes and low platelet(HELLP) syndrome associated with systemic lupus erythematosus. Intern Med 2003; 42: 1052-3.
12. Murphy MA, Ayazifar M. Permanent visual deficits secondary tothe HELLP syndrome. J Neuro ophthalmol 2005; 25: 122-7
13. Koenen SV, Huisjes AJ, Dings J, van der GY, Visser GH, Bruinse HW. Is there a diurnal pattern in the clinical symptoms of HELLPsyndrome? J Matern Fetal Neonatal Med 2006; 19: 93-9.
14. Smulian JC, Shen-Schwarz S, Scorza WE, Kinzler WL, VintzileosAM. A clinicohistopathological comparison between HELLP syndromeand severe pre-eclampsia. J Matern-Fetal and Neonatal Med 2004; 16: 287-93.
15. Haddad B, Barton JR, Livingston JC, Chahine R, Sibai BM. Riskfactors for adverse maternal outcomes among women with HELLP(hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2000; 183: 444-8.
16. Svenningsen R, Morken NH, Kahn JA. Corticosteroids in thetreatment of HELLP-syndrome? Tidsskr Nor Laegeforen 2006;126: 2253-6.
17. Aldemir M, Bac B, Tacyildizil I, Yagmur Y, Keles C. Spontaneousliver haemtoma and a hepatic rupture in HELLP syndrome: a reportof two cases. Surg Today 2002: 450-3
18. Tranquilli AL, Giannubilo SR, Tedeschi E, Bezzeccheri V, SuzukiH, Menegazzi M. Placental expression of nitric oxide sytnthaseduring HELLP syndrome: the correlation with maternal -fetalDoppler velocimetry. Acta Obstet Gynecol Scand 2005; 84: 849-53.
19. Martin JN, Jr, Thigpen BD, Rose CH, Cushman J, Moore A, MayWL. Maternal benefit of high-dose intravenous corticosteroid therapyfor HELLP syndrome. Am J Obstet Gynecol 2003; 189: 830-4.
20. Deruelle P, Coudoux E, Ego A, Houfflin-Debarge V, Codaccioni X, Subtil D. Risk factors for post-partum complications occurringafter pre-eclampsia and HELLP syndrome. A study in 453 consecutivepregnancies. Euro J Obstet Gynecol Reprod Biol 2006; 125:59-65.
21. van Runnard Heimel PJ, Franx A, Schobben AF, Huisjes AJ, DerksJB, Bruinse HW. Corticosteroids, pregnancy, and HELLP syndrome:a review. Obstet Gynecol Surv 2005; 60: 57-70
22. Baxter JK and Weinstein L. HELLP syndrome: state of the art.Obstet Gynecol Sur 2004; 59: 838-45.
23. Pokharel SM, Chattopadhyay SK, Jaiswal R, Shakya P. HELLPsyndrome-a pregnancy disorder with poor prognosis. Nepal MedColl J 2008; 10(4): 260-3.
24. Lockitch G. The effect of normal pregnancy on common biochemicaland haematological tests in Barron WM, Lindheimer MD Eds. Medical Disorders during Pregnancy. Mosby, St Louis 2000; 635-46.
25. Parnas M, Sheiner E, Shoham-Vardi I, et al. Moderate to severethrombocytopenia during pregnancy. Euro J Obstet Gynecol ReprodBiol 2006; 128: 163-8.
26. Landi B, Tranquilli AL. HELLP syndrome and placental inflammatorypathology. Minerva Gynecol 2008; 60(5): 389-90
27. Young B, Levine RJ, Saluhiddin S, et al. Rana S. The use of angiogenicbiomarkersto differentiatenon-HELLP related thrombocytopeniafrom HELLP syndrome. J Matern Fetal Neonatal Med 2008; 17: 1-7.
28. Zhion CC, Ahmad S, Mi T, et al. Autoantibody from women withpre-eclampsia induces solume fms-like tyrosine kinase-1 productionvia angiotensin 1 receptor and calcineurin/nuclear factor of activatedT-cell signalling. Hypertension 2008; 51: 1010-9.
29. Cavkaytar S, Ugurlu EN, Karaer A, Tapisiz OL, Danisman N. Areclinical symptoms more predictive than laboratory parameters foradverse maternal outcome in HELLP syndrome? Acta Obstet GynecolScand 2007; 86: 648-51.
30. Lindheimer MD, Kanter D. Interpreting abnormal proteinuria inpreg: the need for a more pathopysiological approach. Obstet Gynecol 2010; 115(2pt1): 365-75.
31. Jayanthi V, Udayakumar N. Acute liver failure in pregnancy: anoverview. Minerva Gastroenterol Dietol 2008; 54(1): 75-84.
32. Devarbhavi H, Kremers WK, Dierkhising R, Padmanabhan L. Preganacy associated acute liver disease and acute viral hepatitis:differentiation, course and outcome. J Hepatol 2008; 49 (6): 930-35.
33. Czlonkowska A, Gromadzka G, Büttner J, Chabik G. Clinicalfeatures of haemolysis, elevated liver enzymes, and low plateletcount syndrome in undiagnosed Wilson disease: report of twocases. Arch Gynecol Obstet 2009; 15: 24-56.
34. Kamen B, Karwal MA, Yankowitz J. Hemolysis and elevatedtransaminases imitating severe pre-eclampsia. Obstet Gynecol 2009; 113(2 Pt 2): 545-7.
35. Rehberg JF, Briery CM, Hudson WT, Bofill JA, Martin JN Jr. Thrombotic thrombocytopenic purpura masquerading as hemolysis,elevated liver enzymes, low platelets (HELLP) syndrome in latepregnancy. Obstet Gynecol 2006; 108: 817-20.
36. Gallwas J, Ackerman H, Friedmann W. Thrombotic thrombocytopenicpurpura-a rare and difficult differential diagnosis to HELLPsyndrome in late pregnancy. Z Geburtshilfe Neonatol 2008; 212(2):64-6.
37. Ibdah JA. Acute fatty liver of pregnancy: an update on pathogenesisand clinical implications. World J Gastroenterol 2006; 12: 7397-404.
38. Hepburn IS, Schade RR. Pregnancy associated liver disorders. DigDis Sci 2008; 53(9): 2334-58.
39. Sukenik-Halevy R, Ellis MH, Fejgin MD. Management of immunethrombocytopenic purpura in pregnancy. Obstet Gynecol Survey 2008; 63: 182-7.
40. Martin JN, Jr, Bailey AP, Rehberg JF, Owens MT, Keiser SD, May WL. Thrombotic thrombocytopenic purpura in 166 pregnancies:1955-2006. Am J Obstet Gynecol 2008; 199 (2): 98-104.
41. Groot E, de Groot PG, Fijnheer R, Lenting PG. The presence ofactive von Willebrand factor under various pathological conditions. Curr Opin Hematol 2007; 14: 284-89
42. Moake JL. Thrombotic thrombocytopenic purpura. The systemicclumping "plague". Ann Rev Med 2002; 53: 75-88.
43. Castiglione F, Buccoliero AM, Garbini F, et al. Placental findingsin pregnancy associated haemolytic uremic syndrome: clinicomorphologicalstudy of three cases. Pathologica 2008; 100(6): 451-3.
44. Fang CJ, Richards A, Liszewski MK, Kavanagh D, Atkinson JP.Advances in the understanding of pathogenesis of aHUS andHELLP. Br J Haematol 2008; 143(3): 336-48.
45. Le Thi TD, Tieulie N, Costedoat N, et al. The HELLP syndrome inthe antiphospholipid syndrome: retrospective study of 16 cases in15 women. Ann Rheum Dis 2005; 64: 273-8.
46. Yücesoy, Ozkan S, Bodur H, et al. Maternal and perinatal outcomein pregnancies complicated with hypertensive disorder ofpregnancy: a seven year experience of a tertiary care center. ArchGynecol Obstet 2005; 273: 43-9
47. Ellison J, Sattar N, Greer I. HELLP syndrome: mechanisms andmanagement. Hosp Med 1999; 60: 243-9.
48. Detti L, Mecacci F, Piccioli A, et al. Postpartum heparin therapyfor patients with the syndrome of hemolysis, elevated liver enzymes,and low platelets (HELLP) is associated with significanthemorrhagic complications. J Perinatol 2005; 25: 236-40.
49. Martin JN, Jr, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe pre-eclampsia: comparativeanalysis by HELLP (hemolysis, elevated liver enzyme levels, andlow platelet count) syndrome classification. Am J Obstet Gynecol 1999; 180:1373-84.
50. Gul A, Aslan H, Cebeci A, Polat I, Ulusoy S, Ceylan Y. Maternaland fetal outcomes in HELLP syndrome complicated with acuterenal failure. Renal Failure 2004; 26: 557-62.
51. Erbagci I, Karaca M, Ugur MG, Okumus S, Bekir NA. Opthalmicmanifestations of 107 cases with hemolysis, elevated liver enzymesand low platelet count syndrome. Saudi Med J 2008; 29(8): 1160-3.
52. Taskapili M, Kocabora S, Gulkilik G. Unusual ocular complicationsof the HELLP syndrome: persistent macualr elevation andlocalised tractional retinal detachment. Ann Ophthamol 2007;39(3): 261-3.
53. Stewart MW, Brazis PW, Guier CP, Thota SH, Wilson SD. Purtscher-like retinopathy in a patient with HELLP syndrome. AmJ Ophthalmol 2007; 143: 886-7.
54. Zeidman LA, Videnovic A, Bernstein LP, Pellar CA. Lethal pontinehemorrhage in postpartum syndrome of hemolysis, elevatedliver enzyme levels, and low platelet count. Arch Neurol 2005;62:1150-3.
55. Osmanagaoglu MA, Osmanagaoglu S, Ulusoy H, Bozkaya H. Maternal outcome in HELLP syndrome requiring intensivecare management in a Turkish hospital. Sao Paulo Med J 2006;124: 85-9.
56. Yokota H, Miyamoto K, Yokoyama K, Noguchi H, Uyama K, Oku M. Spontaneous acute subdural haematoma and intracerebral hemorrhagein patient with HELLP syndrome: case report. Acta Neurochir 2009; 22: 12-5.
57. Curtin WM, Weinstein L. A review of HELLP syndrome. J Perinatol 1999; 19: 138-43.
58. Soh Y, Yasuhi I, Nakayama D, Ishimaru T. A case of postpartumcerebellar infarction with hemolysis, elevated liver enzymes, lowplatelets (HELLP) syndrome. Gynecol Obstet Invest 2002; 53: 240-2.
59. Sutton BC, Dunn ST, Landrum J, Mielke G. Fatal postpartum spontaneousliver rupture: case report and literature review. J ForensicSci 2008; 53(2): 472-5.
60. Araujo AC, Leao MD, Nobrega MH, Bezerra PF, Pereira FV, DantasEM, Azevedo GD, Jeronimo SM. Characteristics and treatmentof hepatic rupture caused by HELLP syndrome. Am J Obstet Gynecol 2006; 195: 129-33.
61. Das CJ, Srivastava DN, Debnath J, Ramchandran V, Pal S, SahniP. Endovascular management of hepatic hemorrhage and subcapsularhematoma in HELLP syndrome. Indian J Gastroenterol 2007;26: 244-5.
62. Hay JE. Liver disease in pregnancy. Hepatology 2008; 47(3): 1067-76.
63. Dessole S, Capobianco G, Virdis P, Rubattu G, Cosmi E, Porcu A. Hepatic rupture after caesarean section in a patient with HELLPsyndrome: a case report and review of the literature. Arch GynecolObstet 2007; 276(2): 189-92
64. Pauzner R, Dulitzky M, Carp H, et al. Hepatic infarctions duringpregnancy are associated with the antiphospholipid syndrome andin addition with complete or incomplete HELLP syndrome. JThromb Haemost 2003; 1: 1758-63.
65. Virgil-De Gracia. Pregnancy complicated by pre-eclampsiaeclampsiawith HELLP syndrome. Int J Gynecol Obstet 2001;72(1): 17-23.
66. Isler CM, Magann EF, Rinehart BK, Terrone DA, Bass JD, Martin JN Jr. Dexamethasone compared with betamethasone for glucocorticoidtreatment of postpartum HELLP syndrome. Int J GynaecolObstet 2003; 80: 291-7.
67. Simic M, Tasic M, Stojiljkovic G, Draskovic D, Vukovic R. HELLP syndrome as a cause of unexpected rapid maternal death -a case report and review of the literature. Int J Legal Med 2005;119:103-6.
68. Aslan H, Gul A, Cebeci A. Neonatal outcome in pregnancies afterpreterm delivery for HELLP syndrome. Gynecol Obstet Invest 2004; 58: 96-9.
69. Singhal N, Amin HJ, Pollard JK, et al. Maternal haemolysis, elevatedliver enzymes and low platelets syndrome: perinatal and neurodevelopmentalneonatal outcomes for infants weighing less than1250 g. J Paediatr Child Health 2004; 40: 121-6.
70. Harms K, Rath W, Herting E, Kuhn W. Maternal hemolysis, elevatedliver enzymes. Low platelet count, and neonatal outcome. Am J Perinatol 1995; 12: 1-6.
71. Mihu D, Costin N, Mihu CM, Seicean A, Ciortea R. HELLP syndromea multisystemic disorder. J Gastrointestinal Liver Dis 2007; 16: 419-24.
72. Gasem T, Al Jama FE, Burshaid S, Rahman J, Al Suleiman SA, Rahman MS. Maternal and fetal outcome of pregnancy complicatedby HELLP syndrome. J Matern Fetal Neonatal Med 2009;12: 1-4.
73. Rojas Feria P, Losada Martínez A, Miranda Guisado ML. Neonatalcomplications associated to HELLP syndrome. Ann Pediatr (Barc)2009;70(2):159-63.
74. Roelofsen AC, van Pampus MG, Aarnoudse JG. The HELLPsyndrome;maternal-fetal outcome and follow up of infants. J PerinatMed 2003; 31: 201-8.
75. Murray D, O'Riordan M, Geary M, Phillips R, Clarke T, McKenna P. The HELLP syndrome: maternal and perinatal outcome. IrishMed J 2001; 94:16-8.
76. Gul A, Cebeci A, Aslan H, Polat I, Ozdemir A, Ceylan Y. Perinataloutcomes in severe pre-eclampsia-eclampsia with and without HELLP syndrome. Gynecol Obstet Invest 2005; 59:113-8.
77. Cappell MS. Hepatic disorders severely affected by pregnancy:medical and obstetric management. Med Clin North Am 2008;92(4): 739-6
78. Hupuczi P, Nagy B, Sziller I, Rigo B, Hruby E, Papp Z. Characteristiclaboratory changes in pregnancies complicated by HELLPsyndrome. Hypertens Preg 2007; 26: 389-401
79. O'Brien JM, Barton JR. Controversies with the diagnosis and managementof HELLP syndrome. Clin Obstet Gynecol 2005; 48: 460-77.
80. Osmanagaoglu MA, Erdogan I, Zengin U, Bozkaya H. Comparisonbetween HELLP syndrome, chronic hypertension, and superimposedpre-eclampsia on chronic hypertension without HELLP syndrome. J Perinat Med 2004; 32: 481-5.
81. O'Brien JM, Shumate SA, Satchwell SL, Milligan DA, Barton JR. Maternal benefit of corticosteroid therapy in patients with HELLP(hemolysis, elevated liver enzymes, and low platelet count) syndrome:impact on the rate of regional anesthesia. Am J Obstet Gynecol 2002; 186: 475-9
82. Matchaba P, Moodley J. Corticosteroids for HELLP syndrome inpregnancy. Cochrane Database Syst Rev 2004: CD002076
83. Ozer A, Kanat-Pektas M, Ozer S, et al. The effects of betamethasoneon clinical and laboratory features of pregnant women withHELLP syndrome. Arch Gynecol Obstet 2009; 280(1): 65-70.
84. Pridjian G, Puschett JB. Pre-eclampsia. Part 1: clinical and pathophysiologicconsiderations. Obstet Gynecol Surv 2002; 57: 598-618.
85. Drakeley AJ, Le Roux PA, Anthony J, Penny J. Acute renal failurecomplicating severe pre-eclampsia requiring admission to an obstetricintensive care unit. Am J Obstet Gynecol 2002; 186: 253-6.
86. Katz L, de Amorim MM, Miranda GV, Pinto e Silva, JL. Postpartumdexamethasone for women with hemolysis, elevated liverenzymes, and low platelets (HELLP) syndrome: a double-blind,placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 2008; 199: 46-55.
87. Bayraktaroglu Z, Demirci F, Balat O, Kutlar I, Okan V, Ugur G.Plasma exchange therapy in HELLP syndrome: A single-centerexperience. Turkish J Gastroenterol 2006; 17: 99-102.
88. Vigil-De GP. Addition of platelet transfusions to corticosteroidsdoes not increase the recovery of severe HELLP syndrome. Euro JObstet Gynecol Reprod Bio. 2006; 128: 194-8.
89. Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent ortreat acute renal failure. Br Med J 2006; 333: 420-8.
90. Hupuczi P, Rigo B, Sziller I, Szabo G, Szigeti Z, Papp Z. Followupanalysis of pregnancies complicated by HELLP syndrome. FetalDiagn Ther 2006; 21: 519-22.
91. Dekker G, Robillard PY. The birth interval hypothesis-does itreally indicate the end of the primipaternity hypothesis. J ReprodImmunol 2003; 59: 245-51.